Daniel J Landsburg, MD

faculty photo
Assistant Professor of Clinical Medicine
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-182
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-615-7361
Fax: 215-615-5888
Education:
BA
University of Pennsylvania, 2004.
MD
Temple University School of Medicine, 2008.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Non-Hodgkin lymphoma
Hodgkin lymphoma
Autologous stem cell transplantation

Description of Other Expertise

Clinical operations
Quality improvement
Patient safety

Description of Research Expertise

Double-hit B cell lymphoma
MYC-altered B cell lymphoma
Diffuse large B cell lymphoma
Aggressive B cell lymphoma

Selected Publications

Landsburg, D. J., Koike, A., Nasta, S. D., Svoboda, J., Schuster, S. J., Wasik, M. A., Caponetti, G. C.: Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas. Cancer Immunol Immunother Aug 28 2020 Notes: doi: 10.1007/s00262-020-02708-3.

Ayers, E. C., Margolis, D., Landsburg, D. J.: Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent Therapies. Clin Lymphoma Myeloma Leuk 2020 Notes: PMID: 32576502.

Frosch, Z. A. K., Landsburg, D. J.: Molecular Risk Stratification in Aggressive B-Cell Lymphomas. J Clin Oncol 38(18): 2014-2017, 2020.

Landsburg, D. J., Ayers, E. C., Bond, D. A., Maddocks, K. J., Karmali, R., Behdad, A., Curry, M., Wagner-Johnston, N. D., Modi, D., Ramchandren, R., Assouline, S. E., Faramand, R., Chavez, J. C., Torka, P., Mier Hicks, A., Medeiros, L. J., Li, S.: Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy. Br J Haematol 189(2): 313-317, 2020.

Ayers, E. C., Li, S., Medeiros, L. J., Bond, D. A., Maddocks, K. J., Torka, P., Mier Hicks, A., Curry, M., Wagner-Johnston, N. D., Karmali, R., Behdad, A., Fakhri, B., Kahl, B. S., Churnetski, M. C., Cohen, J. B., Reddy, N. M., Modi, D., Ramchandren, R., Howlett, C., Leslie, L. A., Cytryn, S., Diefenbach, C. S., Faramand, R., Chavez, J. C., Olszewski, A. J., Liu, Y., Barta, S. K., Mukhija, D., Hill, B. T., Ma, H., Amengual, J. E., Nathan, S., Assouline, S. E., Orellana-Noia, V. M., Portell, C. A., Chandar, A., David, K. A., Giri, A., Hess, B. T., Landsburg, D. J.: Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. Cancer 126(2): 293-303, 2020.

Landsburg, D. J., Kahl, B. S.: Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies? Clin Lymphoma Myeloma Leuk 19(2): 65-67, 2019.

Landsburg, D. J., Hughes, M. E., Koike, A., Bond, D., Maddocks, K. J., Guo, L., Winter, A. M., Hill, B. T., Ondrejka, S. L., Hsi, E. D., Nasta, S. D., Svoboda, J., Schuster, S. J., Bogusz, A. M.: Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. Blood Adv 3(2): 132-135, 2019.

Rhodes, J., Landsburg, D. J.: Small-Molecule Inhibitors for the Treatment of Diffuse Large B Cell Lymphoma. Curr Hematol Malig Rep 13(5): 356-368, 2018.

Cherng, H. J., Sargent, R. L., Nasta, S. D., Svoboda, J., Schuster, S. J., Mato, A. R., Schrank-Hacker, A., Morrissette, J. J. D., Landsburg, D. J.: Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non-Burkitt Aggressive B-cell Lymphoma. Clin Lymphoma Myeloma Leuk 18(10): 673-678, 2018.

Landsburg, D. J.: Advancing the management of double hit lymphoma. Oncotarget 8(45): 78245-78246, 2017.

Landsburg, D. J., Falkiewicz, M. K., Maly, J., Blum, K. A., Howlett, C., Feldman, T., Mato, A. R., Hill, B. T., Li, S., Medeiros, L. J., Torka, P., Hernandez-Ilizaliturri, F., Reddy, N. M., Singavi, A., Fenske, T. S., Chavez, J. C., Kaplan, J. B., Behdad, A., Petrich, A. M., Bast, M. A., Vose, J. M., Olszewski, A. J., Costa, C., Lansigan, F., Gerson, J. N., Barta, S. K., Calzada, O., Cohen, J. B., Lue, J. K., Amengual, J. E., Rivera, X., Persky, D. O., Peace, D. J., Nathan, S., Cassaday, R. D.: Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission. J Clin Oncol 35(20): 2260-2267, 2017.

back to top
Last updated: 03/02/2021
The Trustees of the University of Pennsylvania